(Q58050882)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

Single agent dexamethasone for pre-stem cell transplant induction therapy for multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

0 references

1 reference

stem cell transplantation

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

S. Vincent Rajkumar

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Rafael Fonseca

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

12

Litzow MR

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

13

Gertz MA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

9

Lust JA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

2

Lacy MQ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

Kumar S

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Geyer S

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Allmer C

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Witzig TE

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Greipp PR

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

Kyle RA

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

language of work or name

English

0 references

publication date

1 September 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

number of pages

6

1 reference

Bone Marrow Transplantation

inferred from page(s)

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

485-490

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Effective treatment of advanced multiple myeloma refractory to alkylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Single agent vincristine by infusion in refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

A phase II study of idarubicin (4-demethoxydaunorubicin) in advanced myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Oral idarubicin as a single agent therapy in patients with relapsed or resistant multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Do anthracyclines have a role in the therapy of multiple myeloma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Thalidomide alone or with dexamethasone for previously untreated multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Combination therapy with thalidomide plus dexamethasone for newly diagnosed myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

Long-term survival in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

1 reference

7 January 2021

Combination chemotherapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

High-dose intravenous melphalan for plasma-cell leukaemia and myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

High-dose therapy autotransplantation/intensification vs continued standard chemotherapy in multiple myeloma in first remission. Results of a non-randomized study from a single institution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

High-dose glucocorticoid treatment of resistant myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

High-dose dexamethasone for refractory or relapsing multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

A phase II study of idarubicin and prednisone in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704633

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1704633

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15286691%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference